AMS

American Shared Hospital Services (AMS) 10Y Growth Potential Analysis (2026)

Invetso Score: 5.4/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Revenue Growth Drivers

Score: 5.8 (Moderate)

Revenue growth capacity is supported by an established industrial footprint, but the absence of disclosed 5-year CAGR data limits evidence of sustained compounding versus peers.

Low capex intensity at 6.0% of revenue suggests some reinvestment flexibility, yet it also implies a mature base with less visible organic expansion than faster-growing peers.

The company can still scale through incremental demand capture and operational leverage, but negative TTM ROIC indicates current growth is not yet translating into efficient value creation.

Compared with higher-growth peers, AMS appears more capable of steady revenue maintenance and selective expansion than of delivering rapid multi-year top-line acceleration.

Market Tailwinds

Score:

Long-term demand support exists from diversified industrial and technology end markets, but the available evidence does not show stronger structural tailwinds than direct peers.

The company benefits from broad customer exposure, yet peer leaders with clearer secular demand exposure typically have more visible multi-year revenue compounding.

No disclosed concentration metrics or segment growth data indicate a uniquely advantaged end-market mix, limiting confidence in above-peer organic expansion.

Relative to peers with stronger recurring demand or faster structural adoption curves, AMS appears positioned for durable but not exceptional market-driven growth.

Scalability Expansion

Score:

Scalability is constrained by a 108.9-day cash conversion cycle, which ties up working capital and reduces the speed of reinvestment versus more efficient peers.

Net debt to EBITDA of 4.5x and negative interest coverage reduce financial flexibility, limiting the pace at which the company can fund expansion.

Capex remains manageable, but the lack of R&D intensity and weak current profitability suggest expansion is more incremental than platform-like.

Compared with peers that can reinvest cash faster and compound through higher-margin growth, AMS shows moderate scaling capacity rather than structurally superior expansion.

Constraints Limitations

Score:

High leverage and negative interest coverage create a meaningful structural constraint because debt service can absorb cash that would otherwise support growth investment.

Negative TTM ROIC suggests current capital deployment is not yet producing efficient expansion, which weakens long-term compounding versus better-performing peers.

The long cash conversion cycle slows internal funding generation, making growth more dependent on external balance-sheet capacity than on self-funded reinvestment.

These constraints do not imply impaired viability, but they do cap AMS below peers with stronger balance-sheet flexibility and faster capital recycling.

Overall Score

Score:

AMS shows durable but moderate long-term growth capacity, with reinvestment and scale limited by leverage, weak current returns, and slower working-capital conversion versus stronger peers.

Score Driver: Working Capital And Leverage

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on American Shared Hospital Services. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →